These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 35599363)
1. Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection. Kayes T; Crane H; Symonds A; Dumond J; Cottrell M; Di Girolamo J; Manandhar S; Lim TH; Gane E; Kashuba A; Levy MT Aliment Pharmacol Ther; 2022 Aug; 56(3):510-518. PubMed ID: 35599363 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load. Li B; Liu Z; Liu X; Liu D; Duan M; Gu Y; Liu Q; Ma Q; Wei Y; Wang Y Hepatol Int; 2021 Oct; 15(5):1103-1108. PubMed ID: 34312798 [TBL] [Abstract][Full Text] [Related]
3. Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method. Yang N; Zhou G; Cheng X; He J; Chen Y; Chen C; Li M; Ge J; Wang M; Zhang T; Ge W; Zhu H; Han G Front Pharmacol; 2021; 12():734760. PubMed ID: 34483946 [TBL] [Abstract][Full Text] [Related]
4. Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis. Pan CQ; Zhu L; Yu AS; Zhao Y; Zhu B; Dai E Clin Infect Dis; 2024 Oct; 79(4):953-964. PubMed ID: 38805690 [TBL] [Abstract][Full Text] [Related]
5. Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network. Bukkems VE; Necsoi C; Hidalgo Tenorio C; Garcia C; Alba Alejandre I; Weiss F; Lambert JS; van Hulzen A; Richel O; Te Brake LHM; van der Meulen E; Burger D; Konopnicki D; Colbers A Clin Infect Dis; 2022 Sep; 75(4):623-629. PubMed ID: 34864950 [TBL] [Abstract][Full Text] [Related]
6. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes. Chen HL; Lee CN; Chang CH; Lai MW; Tsai MC; Mu SC; Liu CJ; Shih JC; Wen WH; Hu RT; Huang CP; Hu KC; Chen CP; Lee CL; Chien RN; Chang KC; Hsu HY; Lee CC; Ni YH; Chang MH Liver Int; 2024 Jun; 44(6):1422-1434. PubMed ID: 38456620 [TBL] [Abstract][Full Text] [Related]
7. Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate. Li S; Jin J; Jiang Y; Shi J; Jiang X; Lin N; Ma Z Int J Antimicrob Agents; 2023 Mar; 61(3):106726. PubMed ID: 36646229 [TBL] [Abstract][Full Text] [Related]
8. Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy. Bukkems VE; Smolders EJ; Jourdain G; Burger DM; Colbers AP; Cressey TR; J Clin Pharmacol; 2021 Mar; 61(3):388-393. PubMed ID: 32960984 [TBL] [Abstract][Full Text] [Related]
9. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study. Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Chen ZM; Cui GL; Li W; Zhang DW; Li J; Lv J; Li ZQ; Liang HX; Sun CY; Pan YJ; Liu YM; Wang FS Clin Infect Dis; 2021 Nov; 73(9):e3324-e3332. PubMed ID: 33395488 [TBL] [Abstract][Full Text] [Related]
10. The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B. Zhu L; Park J; Deng Y; Pan CQ J Clin Gastroenterol; 2023 Feb; 57(2):127-138. PubMed ID: 36598804 [TBL] [Abstract][Full Text] [Related]
11. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption. Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257 [TBL] [Abstract][Full Text] [Related]
12. Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide. Lalley-Chareczko L; Hiserodt E; Moorthy G; Zuppa A; Mounzer K; Koenig H Front Pharmacol; 2020; 11():286. PubMed ID: 32265700 [No Abstract] [Full Text] [Related]
13. Comparison of the efficacy and safety of TAF, TDF, and LdT to prevent the transmission of hepatitis B in pregnant women: A retrospective study. Pan S; Zhang Y; Zeng Y; Lin C Immun Inflamm Dis; 2024 Feb; 12(2):e1204. PubMed ID: 38414328 [TBL] [Abstract][Full Text] [Related]
14. Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide. Podany AT; Bares SH; Havens J; Dyavar SR; O'Neill J; Lee S; Fletcher CV; Swindells S; Scarsi KK AIDS; 2018 Mar; 32(6):761-765. PubMed ID: 29334548 [TBL] [Abstract][Full Text] [Related]
15. Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study. Zeng QL; Zhang HX; Zhang JY; Huang S; Li WZ; Li GM; Pan YJ; Feng YH; Li ZQ; Zhang GF; Xu JH; Lin WB; Xu GH; Liu N; Zhang GQ; Li GT; Li W; Zeng YL; Song N; Wang M; Zhang DW; Chen ZM; Cui GL; Li J; Lv J; Liu YM; Liang HX; Sun CY; Zhou YH; Yu ZJ; Wang FS Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2826-2837.e9. PubMed ID: 34902570 [TBL] [Abstract][Full Text] [Related]
16. Safety of Tenofovir Disoproxil Fumarate Among Breastfeeding Infants of Patients With Chronic Hepatitis B: A Systematic Review. Pak K; Ibrahim B; Saab S J Viral Hepat; 2024 Nov; 31(11):760-767. PubMed ID: 39206721 [TBL] [Abstract][Full Text] [Related]
17. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. Agarwal K; Brunetto M; Seto WK; Lim YS; Fung S; Marcellin P; Ahn SH; Izumi N; Chuang WL; Bae H; Sharma M; Janssen HLA; Pan CQ; Çelen MK; Furusyo N; Shalimar D; Yoon KT; Trinh H; Flaherty JF; Gaggar A; Lau AH; Cathcart AL; Lin L; Bhardwaj N; Suri V; Mani Subramanian G; Gane EJ; Buti M; Chan HLY; ; J Hepatol; 2018 Apr; 68(4):672-681. PubMed ID: 29756595 [TBL] [Abstract][Full Text] [Related]
18. Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV. Pan CQ; Chang TT; Bae SH; Brunetto M; Seto WK; Coffin CS; Tan SK; Mo S; Flaherty JF; Gaggar A; Nguyen MH; Çelen MK; Thompson A; Gane EJ PLoS One; 2021; 16(5):e0251552. PubMed ID: 33984038 [TBL] [Abstract][Full Text] [Related]
19. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults. Ruane PJ; DeJesus E; Berger D; Markowitz M; Bredeek UF; Callebaut C; Zhong L; Ramanathan S; Rhee MS; Fordyce MW; Yale K J Acquir Immune Defic Syndr; 2013 Aug; 63(4):449-55. PubMed ID: 23807155 [TBL] [Abstract][Full Text] [Related]
20. Plasma and Breast Milk Pharmacokinetics of Tenofovir Disoproxil Fumarate in Nursing Mother with Chronic Hepatitis B-Infant Pairs. Erturk US; Mete B; Ozaras R; Saltoglu N; Balkan II; Mert A; Kacmaz B; Saglam O; Guney B; Sayman OA; Tabak F Antimicrob Agents Chemother; 2021 Sep; 65(10):e0111021. PubMed ID: 34310204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]